Alzheimer’s disease is a progressive, degenerative disease that attacks the brain’s nerve cells, resulting in the loss of memory, thinking and language skills. a simple eye test could diagnose early stage Alzheimer’s disease. Two studies (one in the United States and one in Australia) identified a biomarker for the disease that can be located in the retina and lens of the eye. The key indicator for Alzheimer’s disease is a sign of beta-amyloid protein, which clumps in the brains of Alzheimer’s sufferers.

Key Takeaways:

  • 5 year study of patients over 65 with degenerative eye diseases provided a new approach to monitor for early onset of Alzheimer’s disease.
  • Primary Care Physicians and Ophthalmologist should communicate about in-common patients with degenerative eye diseases.
  • Cataract diagnosis is not an early warning sign of Alzheimer disease.

“The main message from this study is that ophthalmologists should be more aware of the risks of developing dementia for people with these eye conditions and primary care doctors seeing patients with these eye conditions might be more careful on checking on possible dementia or memory loss”

Read more: